98%
921
2 minutes
20
Hemispheric specialization is a fundamental feature of human brain organization. However, it is not yet clear to what extent the lateralization of specific cognitive processes may be evident throughout the broad functional architecture of cortex. While the majority of people exhibit left-hemispheric language dominance, a substantial minority of the population shows reverse lateralization. Using twin and family data from the Human Connectome Project, we provide evidence that atypical language dominance is associated with global shifts in cortical organization. Individuals with atypical language organization exhibit corresponding hemispheric differences in the macroscale functional gradients that situate discrete large-scale networks along a continuous spectrum, extending from unimodal through association territories. Analyses reveal that both language lateralization and gradient asymmetries are, in part, driven by genetic factors. These findings pave the way for a deeper understanding of the origins and relationships linking population-level variability in hemispheric specialization and global properties of cortical organization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256741 | PMC |
http://dx.doi.org/10.1038/s41467-023-39131-y | DOI Listing |
Front Immunol
September 2025
Chemical and Biological Engineering, Koc University, Istanbul, Türkiye.
Type 1 diabetes (T1D) is characterized by the autoimmune destruction of pancreatic beta cells, resulting in lifelong insulin therapy that falls short of a true cure. Beta cell replacement therapies hold immense potential to restore natural insulin production, but they face significant hurdles such as immune rejection, limited donor availability, and long-term graft survival. In this review, we explore cutting-edge advances in genetic engineering, biomaterials, and machine learning approaches designed to overcome these barriers and enhance the clinical applicability of beta cell therapies.
View Article and Find Full Text PDFBrain
September 2025
Research Department of Imaging Physics and Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, SE1 7EH, UK.
Despite decades of development and clinical application drug-resistant epilepsy occurs in 25-30% of patients. One limiting factor in the success of anti-seizure medications are challenges in mapping the neural effects of epilepsy drugs to seizure mechanisms in humans. Most anti-seizure medications were developed in animal models and primarily target nano-scale structures like ion channels and receptors.
View Article and Find Full Text PDFChem
August 2025
Advanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow G11 6EW, UK.
The assembly of molecular nanomachines using atomically precise manipulations promises to enable nanotechnology with unprecedented architectural features and exquisite functional properties. However, this future is critically limited by the ability to autonomously manufacture nanomachines, with current efforts being heavily labor intensive. A system is needed to program and assemble matter under digital control, unifying molecular nanotechnology and macroscale chemical processes.
View Article and Find Full Text PDFJ Biomech Eng
September 2025
Department of Biomedical Engineering, The University of Akron, 244 Sumner Street Akron, OH 44325.
The lungs play a critical role in gas exchange and overall respiratory functions, relying on a delicate balance of pulmonary mechanics and surfactant homeostasis. Surfactant replacement therapy (SRT) is a life-saving intervention for conditions such as neonatal respiratory distress syndrome (NRDS), where surfactant deficiency impairs alveolar stability and normal gas exchange. To improve treatment strategies of lung disorders such as NRDS, researchers have developed a variety of computational, benchtop, and animal models to investigate surfactant transport and drug delivery in the lungs.
View Article and Find Full Text PDFSci Rep
August 2025
Faculty of Chemistry, University of Warsaw, 02-093, Warsaw, Poland.
Orexins are hypothalamic neuropeptides primarily involved in regulating the sleep/wakefulness cycle and circadian rhythm. They bind to the orexin receptor type 1 (OX) and type 2 (OX), well-known drug targets in the treatment of sleep disorders, that have recently been shown to play a significant role in different cancers. Lemborexant is one of a few orexin receptor antagonists that have been approved for the treatment of insomnia.
View Article and Find Full Text PDF